ClinicalTrials.gov
ClinicalTrials.gov Menu

CDR Investing in Fatherhood Process Study & Evaluation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03710135
Recruitment Status : Recruiting
First Posted : October 17, 2018
Last Update Posted : October 23, 2018
Sponsor:
Information provided by (Responsible Party):
Laura Parker, Child Development Resources

Brief Summary:
This study will evaluate the Investing in Fatherhood: New Pathways program of Child Development Resources (CDR), a Healthy Marriage and Responsible Fatherhood (HMRF) grantee. The program will deliver parenting education, relationship skills training, job preparedness and financial planning, and case management support. This research will consist of a descriptive process and program evaluation study, with research questions focusing on recruitment and retention and short-term participant outcomes.

Condition or disease
Parenting Parent-Child Relations

Detailed Description:

This study will address three research questions:

  1. Which recruitment strategies are the most successful for participation? CDR will work to expand recruitment efforts and encourage greater participation through a number of strategies, such as offering various incentives and hosting classes in other spaces (e.g. churches, restaurants, clinics). This study will examine which methods are the most effective.
  2. Which engagement/retention strategies are the most successful? Current fatherhood services staff at CDR have expressed difficulty in getting fathers to participate on a regular and steady basis in fatherhood services. CDR will explore several strategies for increased retention and this study will evaluate these strategies.
  3. Do fathers who participate in the program earlier in their fatherhood experience (e.g. when their oldest child is under five years of age) report better outcomes than fathers who begin receiving fatherhood services later? CDR has extensive knowledge working specifically with young children and families in early intervention programs. In early childhood development, many studies have shown that the highest return on investment comes from early intervention, from birth through age five. The hypothesis is that this principle holds true in responsible fatherhood programming as well.

Study Type : Observational
Estimated Enrollment : 350 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Child Development Resources Investing in Fatherhood: New Pathways - Process Study & Evaluation
Actual Study Start Date : August 1, 2016
Estimated Primary Completion Date : September 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Change in attitudes toward child [ Time Frame: depending on program length, ranges from 30 days to 10 weeks ]
    nFORM (Information, Family Outcomes, Reporting, and Management) questions on pre- and post-survey. Answers range from (1) Never to (4) Often. A higher response indicates a better outcome.

  2. Change in using negative punishment with child [ Time Frame: depending on program length, ranges from 30 days to 10 weeks ]
    nFORM (Information, Family Outcomes, Reporting, and Management) questions on pre- and post-survey. Answers range from (1) Never to (4) Every Day or Almost Every Day. A lower response indicates a better outcome.

  3. Change in time spent with child [ Time Frame: depending on program length, ranges from 30 days to 10 weeks ]
    nFORM (Information, Family Outcomes, Reporting, and Management) questions on pre- and post-survey. Answers range from (1) Never to (4) Every Day or Almost Every Day. A higher response indicates a better outcome.

  4. Change in feeling overwhelmed with parenting responsibilities [ Time Frame: depending on program length, ranges from 30 days to 10 weeks ]
    nFORM (Information, Family Outcomes, Reporting, and Management) questions on pre- and post-survey. Answers range from (1) Never to (4) Often. A lower response indicates a better outcome.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Parents (majority fathers) who participate in CDR's Pathways Fatherhood program, in the community and incarcerated individuals.
Criteria

Inclusion Criteria:

  • Any person enrolled in CDR's Pathways Fatherhood program.

Exclusion Criteria:

  • Any participant who does not give informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03710135


Contacts
Contact: Laura Parker, MPP 757-524-2271 lauraparkerconsulting@gmail.com

Locations
United States, Virginia
Child Development Resources Recruiting
Williamsburg, Virginia, United States, 23188
Contact: Laura Parker    757-524-2271    lauraparkerconsulting@gmail.com   
Principal Investigator: Laura Parker, MPP         
Sponsors and Collaborators
Child Development Resources

Responsible Party: Laura Parker, Local Evaluator, Child Development Resources
ClinicalTrials.gov Identifier: NCT03710135     History of Changes
Other Study ID Numbers: 2016/04/2
First Posted: October 17, 2018    Key Record Dates
Last Update Posted: October 23, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No